Since IL-4 is a well-recognized anti-inflammatory cytokine [59], our findings are suggestive that in epileptogenic lesions of FCD IIb and TSC, anti-inflammatory cytokines like IL-4 are deficient and that decreased expression of CD200 may be partially caused by insufficient IL-4 level. The gene discussed is CD200; the disease is tuberous sclerosis.